Evidence map›Paper›PMID 32638172›Full record

ReviewCurrent pain and headache reports2020

Intravenous Migraine Treatment in Children and Adolescents.

Klaus Werner, Sharoon Qaiser, Marielle Kabbouche, Beverly Murphy, Ian Maconochie, Andrew D Hershey

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Non-Pharmacological Treatments in Paediatric Migraine.Journal of clinical medicine · 2024
    Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Klaus WernerDivision of Pediatric Neurology, Duke University Medical Center, Durham, NC, USA. klaus.werner@duke.edu.ORCID http://orcid.org/0000-0002-9314-8076
Sharoon QaiserDepartment of Neurology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, E4-310, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Marielle KabboucheDepartment of Neurology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, E4-310, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Beverly MurphyMedical Center Library & Archives, Duke University Medical Center, Durham, NC, 27710, USA.
Ian MaconochieImperial College Healthcare NHS Trust, London, UK.
Andrew D HersheyDepartment of Neurology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, E4-310, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewPediatric migraine is a common, chronic, and disabling neurological disorder in children and adolescents. Outpatient management is not always effective, and intravenous migraine management may be necessary for headache treatment in the pediatric emergency department. Most current treatment is based on retrospective evidence and there is a lack of well-designed randomized double-blinded controlled pediatric studies. Intravenous drug treatment agents including intravenous fluids, prochlorperazine, diphenhydramine, metoclopramide, dexamethasone, magnesium, valproate and propofol, and dihydroergotamine are reviewed in this paper. RECENT

findingsNineteen studies were reviewed including one prospective randomized double-blind; one single-blinded randomized; one prospective; and one open-label, randomized clinical trial. Most studies were retrospective and the quality of the studies was limited. No definite conclusions can be drawn from the studies, but appropriate prospective trials between major pediatric headache institutions will move pediatric intravenous migraine management forward.

Indexed as

Administration, IntravenousAdolescentAkathisia, Drug-InducedAnesthetics, LocalAntibodies, Monoclonal, HumanizedAnti-Inflammatory Agents, Non-SteroidalBasal Ganglia DiseasesChildDexamethasoneDihydroergotamineDiphenhydramineDopamine AntagonistsEmergency Service, HospitalEnzyme InhibitorsFluid TherapyGlucocorticoidsAnesthetics, LocalAntibodies, Monoclonal, HumanizedAnti-Inflammatory Agents, Non-SteroidalDexamethasoneDihydroergotamineDiphenhydramineDopamine AntagonistsEnzyme InhibitorseptinezumabGlucocorticoidsHypnotics and SedativesKetorolacLidocaineMagnesiumProchlorperazinePropofolValproic AcidVasoconstrictor AgentsAcute treatmentIntravenous treatmentPediatric migraineStatus migrainosus

Identifiers

PMID32638172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.